Publication | Closed Access
A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘<scp>APRAISAL</scp>’ study
10
Citations
32
References
2022
Year
Apremilast is a safe and effective treatment for bio-naïve patients with moderate psoriasis and specific psoriasis manifestations.
| Year | Citations | |
|---|---|---|
Page 1
Page 1